Sage Therapeutics
SAGE
#7026
Rank
S$0.70 B
Marketcap
S$11.21
Share price
0.00%
Change (1 day)
3.94%
Change (1 year)

Earnings for Sage Therapeutics (SAGE)

Earnings in 2025 (TTM): -S$0.4 Billion

According to Sage Therapeutics 's latest financial reports the company's current earnings are S$70.41 Million. In 2024 the company made an earning of -S$0.52 Billion, an increase over its 2023 earnings that were of -S$0.7 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sage Therapeutics from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.4 Billion-23.27%
2024 -S$0.52 Billion-26.01%
2023 -S$0.7 Billion1.63%
2022 -S$0.69 Billion16.36%
2021 -S$0.6 Billion-175.55%
2020 S$0.78 B-189.1%
2019 -S$0.88 Billion82.43%
2018 -S$0.49 Billion38.04%
2017 -S$0.35 Billion69.9%
2016 -S$0.21 Billion68.25%
2015 -S$0.13 Billion179.48%
2014 -S$43.67 Million84.98%
2013 -S$23.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regulus Therapeutics
RGLS
-S$61.26 Million-84.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
S$46.05 M-111.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
S$0.66 B-270.17%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
-S$74.93 Million-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA